This inventor holds 1 USPTO granted patent. Top assignee: The General Hospital Corporation. Active years: 1992.
Company Filing History:
Years Active: 1992
Title: The Innovations of Samuel R. Nussbaum
Introduction
Samuel R. Nussbaum is a notable inventor based in Weston, MA (US). He has made significant contributions to the field of biotechnology, particularly in the production of human parathyroid hormone. His work has implications for medical treatments and advancements in genetic engineering.
Latest Patents
Nussbaum holds a patent for a recombinant DNA method for the production of parathyroid hormone. This patent describes a recombinant DNA molecule coding for human parathyroid hormone, which is operably linked to an inducible bacterial promoter, a leader growth hormone sequence, and a selective enzymatic cleavage site. The expression of this molecule in bacteria allows for the production of large quantities of human parathyroid hormone and its variants, showcasing his innovative approach to biotechnology.
Career Highlights
Samuel R. Nussbaum is associated with The General Hospital Corporation, where he has contributed to various research initiatives. His work has been instrumental in advancing the understanding and production of essential hormones through recombinant DNA technology.
Collaborations
Nussbaum has collaborated with esteemed colleagues such as Henry M. Kronenberg and Tomoko Doi. These partnerships have fostered a collaborative environment that enhances research and innovation in the field.
Conclusion
Samuel R. Nussbaum's contributions to biotechnology, particularly through his patent on recombinant DNA methods, highlight his role as an influential inventor. His work continues to impact the medical field and advance scientific understanding.